A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-11, Vol.30, p.ix30 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | ix30 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Lam, G. Tong, M. Lee, J. Chu, S. Ng, D.C. Lam, D.C.M. Cho, C. Hung, E.H. Li, L. Ho, W.M. Hui, E.P. Chan, A.W. Hon, S. Mak, T. Ng, S. Suen, J. Mo, F. Ma, B.B.Y. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz421.001 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz421_001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz421_001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1331-f1bbeb5b5e14f32767f3800117520aaf310958e943a96962eef5b2292d0d00cc3</originalsourceid><addsrcrecordid>eNotkMtOwzAQRb0AiVL4AHbzA239yKNmV1UUIlWqhEBiFzn2mKSkTmQnoPAhfC9GZXU1i3tG9xByx-iSUSlWyrnO6dXJfCecLSllF2RGJReLPBXJFbkO4UgpzSSXM_KzgdPYDo1GN6CHvlYBoSggDKOZoLPgsFPmOH4qN8DusN8d3ornAmzXtt0XGqgm0PHZ6H0EgFY96mZQVeMQlDPglWm6oUav-imWPNTNew2-CR_gUQ-qjRWn0d_DBmzj4u2x7_xwQy6tagPe_uecvO4eXrZPi_3hsdhu9gvNhGALy6oKq7RKkSVW8DzLrVjHwSxPOVXKiugjXaNMhJKZzDiiTSvOJTfUUKq1mBN25mrfheDRlr1vTspPJaPln8zyLLM8yywjW_wCJx1uwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Lam, G. ; Tong, M. ; Lee, J. ; Chu, S. ; Ng, D.C. ; Lam, D.C.M. ; Cho, C. ; Hung, E.H. ; Li, L. ; Ho, W.M. ; Hui, E.P. ; Chan, A.W. ; Hon, S. ; Mak, T. ; Ng, S. ; Suen, J. ; Mo, F. ; Ma, B.B.Y.</creator><creatorcontrib>Lam, G. ; Tong, M. ; Lee, J. ; Chu, S. ; Ng, D.C. ; Lam, D.C.M. ; Cho, C. ; Hung, E.H. ; Li, L. ; Ho, W.M. ; Hui, E.P. ; Chan, A.W. ; Hon, S. ; Mak, T. ; Ng, S. ; Suen, J. ; Mo, F. ; Ma, B.B.Y.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz421.001</identifier><language>eng</language><ispartof>Annals of oncology, 2019-11, Vol.30, p.ix30</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1331-f1bbeb5b5e14f32767f3800117520aaf310958e943a96962eef5b2292d0d00cc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Lam, G.</creatorcontrib><creatorcontrib>Tong, M.</creatorcontrib><creatorcontrib>Lee, J.</creatorcontrib><creatorcontrib>Chu, S.</creatorcontrib><creatorcontrib>Ng, D.C.</creatorcontrib><creatorcontrib>Lam, D.C.M.</creatorcontrib><creatorcontrib>Cho, C.</creatorcontrib><creatorcontrib>Hung, E.H.</creatorcontrib><creatorcontrib>Li, L.</creatorcontrib><creatorcontrib>Ho, W.M.</creatorcontrib><creatorcontrib>Hui, E.P.</creatorcontrib><creatorcontrib>Chan, A.W.</creatorcontrib><creatorcontrib>Hon, S.</creatorcontrib><creatorcontrib>Mak, T.</creatorcontrib><creatorcontrib>Ng, S.</creatorcontrib><creatorcontrib>Suen, J.</creatorcontrib><creatorcontrib>Mo, F.</creatorcontrib><creatorcontrib>Ma, B.B.Y.</creatorcontrib><title>A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkMtOwzAQRb0AiVL4AHbzA239yKNmV1UUIlWqhEBiFzn2mKSkTmQnoPAhfC9GZXU1i3tG9xByx-iSUSlWyrnO6dXJfCecLSllF2RGJReLPBXJFbkO4UgpzSSXM_KzgdPYDo1GN6CHvlYBoSggDKOZoLPgsFPmOH4qN8DusN8d3ornAmzXtt0XGqgm0PHZ6H0EgFY96mZQVeMQlDPglWm6oUav-imWPNTNew2-CR_gUQ-qjRWn0d_DBmzj4u2x7_xwQy6tagPe_uecvO4eXrZPi_3hsdhu9gvNhGALy6oKq7RKkSVW8DzLrVjHwSxPOVXKiugjXaNMhJKZzDiiTSvOJTfUUKq1mBN25mrfheDRlr1vTspPJaPln8zyLLM8yywjW_wCJx1uwA</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Lam, G.</creator><creator>Tong, M.</creator><creator>Lee, J.</creator><creator>Chu, S.</creator><creator>Ng, D.C.</creator><creator>Lam, D.C.M.</creator><creator>Cho, C.</creator><creator>Hung, E.H.</creator><creator>Li, L.</creator><creator>Ho, W.M.</creator><creator>Hui, E.P.</creator><creator>Chan, A.W.</creator><creator>Hon, S.</creator><creator>Mak, T.</creator><creator>Ng, S.</creator><creator>Suen, J.</creator><creator>Mo, F.</creator><creator>Ma, B.B.Y.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201911</creationdate><title>A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report</title><author>Lam, G. ; Tong, M. ; Lee, J. ; Chu, S. ; Ng, D.C. ; Lam, D.C.M. ; Cho, C. ; Hung, E.H. ; Li, L. ; Ho, W.M. ; Hui, E.P. ; Chan, A.W. ; Hon, S. ; Mak, T. ; Ng, S. ; Suen, J. ; Mo, F. ; Ma, B.B.Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1331-f1bbeb5b5e14f32767f3800117520aaf310958e943a96962eef5b2292d0d00cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lam, G.</creatorcontrib><creatorcontrib>Tong, M.</creatorcontrib><creatorcontrib>Lee, J.</creatorcontrib><creatorcontrib>Chu, S.</creatorcontrib><creatorcontrib>Ng, D.C.</creatorcontrib><creatorcontrib>Lam, D.C.M.</creatorcontrib><creatorcontrib>Cho, C.</creatorcontrib><creatorcontrib>Hung, E.H.</creatorcontrib><creatorcontrib>Li, L.</creatorcontrib><creatorcontrib>Ho, W.M.</creatorcontrib><creatorcontrib>Hui, E.P.</creatorcontrib><creatorcontrib>Chan, A.W.</creatorcontrib><creatorcontrib>Hon, S.</creatorcontrib><creatorcontrib>Mak, T.</creatorcontrib><creatorcontrib>Ng, S.</creatorcontrib><creatorcontrib>Suen, J.</creatorcontrib><creatorcontrib>Mo, F.</creatorcontrib><creatorcontrib>Ma, B.B.Y.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lam, G.</au><au>Tong, M.</au><au>Lee, J.</au><au>Chu, S.</au><au>Ng, D.C.</au><au>Lam, D.C.M.</au><au>Cho, C.</au><au>Hung, E.H.</au><au>Li, L.</au><au>Ho, W.M.</au><au>Hui, E.P.</au><au>Chan, A.W.</au><au>Hon, S.</au><au>Mak, T.</au><au>Ng, S.</au><au>Suen, J.</au><au>Mo, F.</au><au>Ma, B.B.Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report</atitle><jtitle>Annals of oncology</jtitle><date>2019-11</date><risdate>2019</risdate><volume>30</volume><spage>ix30</spage><pages>ix30-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz421.001</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-11, Vol.30, p.ix30 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz421_001 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T04%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20multicenter%20phase%20II%20study%20of%20neoadjuvant%20FOLFOXIRI%20followed%20by%20concurrent%20capecitabine%20and%20radiotherapy%20for%20high%20risk%20rectal%20cancer:%20A%20final%20report&rft.jtitle=Annals%20of%20oncology&rft.au=Lam,%20G.&rft.date=2019-11&rft.volume=30&rft.spage=ix30&rft.pages=ix30-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz421.001&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz421_001%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |